Histopathological study of Non-neoplastic & Neoplastic ovarian lesions in a tertiary care hospital in Gujarat, India

Maru A.M1,Menapara C.B.2

1Dr. Alpesh M Maru, Assistant Professors, 2Dr. Chiragkumar B. Menapara, Assistant Professors, both authors are affiliated with Department of Pathology, GMERS Medical College& Hospital, Junagadh, Gujarat, India.

Corresponding Author: Dr. Chiragkumar B. Menapara, Assistant Professors; Department of Pathology, GMERS Medical College & Hospital, Junagadh, Gujarat, India. E-mail: drmaru28@gmail.com


Abstract

Aims & Objectives:(1) To know about various histopathological types of ovarian lesions presented and diagnosed at our institute. (2) To study the incidence of ovarian lesions with respect to patient’s age. (3) To study the frequency of ovarian lesions in terms of non-neoplastic or neoplastic, benign or malignant, unilateral or bilateral, etc. Materials & Methods: The present study was performed at the Department of Pathology, GMERS Medical College & Hospital-Junagadh (Gujarat, India) from January 2015 to December 2018 and includes 100 cases of ovarian lesions diagnosed on both clinical & histopathological basis. We have received ovarian specimens and performed routine grossing and H& E staining procedure. We have included parameters like Age wise incidence, Nature of Lesion, Frequency & Laterality in this present study. Results: Out of100 cases, 89% are unilateral and 11% are bilateral. 52% lesions are Benign Neoplasms, 44% lesions are Non-neoplastic Cysts and 4% lesions are Borderline & Malignant Neoplasms. Majority of cases (58%) belong to age group of 20-39 years. Among Non-neoplastic Lesions, Follicular Cyst is common & frequently bilateral while among Benign Neoplasms, Serous Cystadenoma is common & frequently bilateral.Conclusion: Ovarian Lesions both non-neoplastic and neoplastic include a variety of morphological features and show a particular age wise incidence. Role of histopathological evaluation remains always important in both diagnosis & management of such cases, particularly in cases of Malignant Lesions in order to save the patient’s life.

Key words:Non-neoplastic, Benign, Borderline, Malignant, Follicular Cyst, Serous Cystadenoma


Manuscript received: 20th January 2019 Reviewed: 30th January 2019
Author Corrected: 7th February 2019 Accepted for Publication: 11th February 2019

Introduction

Ovarian enlargements (lesions), cystic or solid, may occur at any age [1]. These enlargements may be Non-neoplastic or Neoplastic in nature. Non-Neoplastic Enlargements include Simple Follicular Cysts, Corpus Leuteal Cysts, Chocolate Cysts due to Endometriosis, Twisted Hemorrhagic Cysts, Polycystic Ovarian Disease (PCOD), Various Inflammatory Lesions, etc. To define a functional non-neoplastic cyst, its size or diameter must be at least 3 cm, but not more than 7 cm [1]. Non-Neoplastic Enlargements develop almost exclusively during the childbearing years. They may be asymptomatic or produce local discomfort, menstrual disturbances, infertility, or in rare cases cause acute symptoms due to complications like haemorrhage, rupture or torsion [1].

Neoplastic disorders or lesionsof Ovary can arise from (1) Mullerian epithelium, (2) Germ cells or (3) Sex cord Stromal cells [2]. Classification of Ovarian Neoplasms given by WHO is completely based upon the tissue of origin. It includes a variety of entities like Surface Epithelial Tumors, Sex cord Stromal Tumors, Pure or Mixed Germ Cell Tumors, Gonadoblastoma, Soft Tissue Tumors, Metastatic Tumors, Unclassified Tumors, etc. Surface Epithelial Tumors are further categorized into benign, borderline and malignant [1,3]. Ovarian neoplasms behave in diverse way and generally escape the detection until they attain a larger size. This is primarily due to the reason that either the symptoms are vague or most of these are asymptomatic therefore they manifest over a time period due to no definite screening program. Therefore, diagnosis of various histological patterns of ovarian tumors is very important in the treatment and prognosis. [2]

Aims & Objectives

To know about various histopathological types of ovarian lesions presented and diagnosed at our institute

To study the incidence ofovarian lesions with respect to patient’s age

To study the frequency of ovarian lesions in terms of non-neoplastic or neoplastic, benign or malignant, unilateral or bilateral, etc.

Material & Method

The present retrospective studywas performed at the Department of Pathology, GMERS Medical College& Hospital-Junagadh (Gujarat, India) from January 2015 to December 2018 for a period of 4 years. It includes a total number of 100 random cases of ovarian lesions diagnosed initially on the basis of clinical findings and finally on the basis of histopathological examination.

Nature of Specimens

Solitary Salpingooophorectomy specimens, Unilateral or Bilateral

Hysterectomy with Unilateral Salpingooophorectomy specimens

Hysterectomy with Bilateral Salpingooophorectomy specimens

Inclusion Criteria:All ovarian biopsy with abnormal findings on sonography.

Exclusion Criteria:

1. History of previous chemotherapy or radiotherapy

2. Age below 20 years.

These specimens have been received from Gynecology Department with sufficient & relevant clinical and radiological findings in a specific Performa for further Histopathological Evaluation at our Department. After a number of necessary technical steps like Fixation in 10% Formalin, Gross Examination, Surgical Dissection, Tissue Processing, Paraffin Embedding, Microtomy, staining with routine H-E method & Mounting of Slides using DPX, Microscopic Slides have been made available for further evaluation & final diagnosis.All slides have been viewed by at least two Pathologists before final reporting and all lesions have beenclassified using WHO guidelines. Data are plotted and statistical analysis was carried out with the help of SPSS (Statistical packages for social science) and by using X2- chi square test. P value less than 0.001 is significant.

Results

A total of 100 specimens of ovarian lesions have been received for histopathological evaluation at our department & out of them, 89 lesions are unilateral and 11 lesions are bilateral. 52% lesions are Benign Neoplasms, 44% lesions are Non-neoplastic Cysts and 4% lesions are Borderline & Malignant Neoplasms. Histopathological Categorization of Various Ovarian Lesions is given below in Table no.1 and their Age-wise incidence is given below in Table no.2.

Table No-1: Histopathological Categorization of various Ovarian Lesions

Sr.No.

HistopathologicalDiagnosis or Category

Number of

Cases and %

Unilateral Cases

Bilateral Cases

Non-neoplastic lesions

1

Follicular Cysts

20

17

03

2

Corpus Leuteal Cysts

14

11

03

3

Hemorrhagic Twisted Ovarian Cysts

06

06

--

4

Endometriosis & Chocolate Cysts

04

04

--

Benign neoplasms

5

Serous Cystadenoma

28

24

04

6

Mature Cystic Teratoma

13

13

--

7

Mucinous Cystadenoma

06

05

01

8

Serous Cystadenofibroma

03

03

--

9

Mature Teratoma with Struma Ovarii

01

01

--

10

Brenner’s Tumor (Benign)

01

01

--

Borderline &malignant neoplasms

11

Borderline Mucinous Tumor

01

01

--

12

Papillary Serous Cystadenocarcinoma

01

01

--

13

Granulosa Cell Tumor of Adult Type

01

01

--

14

Dysgerminoma

01

01

--

 

Total

100

89

11

TableNo.-2: Age-wise Incidence of various Ovarian Lesions

Sr. No.

Histopathological

Diagnosis or Category

20-39 years

40-59 years

60 years & above

Total

1

Follicular Cysts

14

06

--

20

2

Corpus Leuteal Cysts

08

06

--

14

3

Hemorrhagic Twisted Ovarian Cysts

06

--

--

06

4

Endometriosis & Chocolate Cysts

--

03

01

04

5

Serous Cystadenoma

15

08

05

28

6

Mature Cystic Teratoma

07

05

01

13

7

Mucinous Cystadenoma

04

01

01

06

8

Serous Cystadenofibroma

03

--

--

03

9

Mature Teratoma with Struma Ovarii

--

01

--

01

10

Brenner’s Tumor (Benign)

--

01

--

01

11

Borderline Mucinous Tumor

--

01

--

01

12

Papillary Serous Cystadenocarcinoma

--

--

01

01

13

Granulosa Cell Tumor of Adult Type

--

01

--

01

14

Dysgerminoma

01

--

--

01

 

Total

58

32

10

100

As mentioned above in both tables, Simple Follicular Cysts are the commonest among all Non-neoplastic Cystic Lesions and often bilateral. Non-neoplastic Cysts are seen in comparatively younger females belonging to age group of 20-39 years and quite rare after menopause because of complete cessation of normal & regular menstrual cycles.

Among various benign neoplasms, Serous Cystadenoma is the commonest & often bilateral. Next common benign neoplasm is Mature Cystic Teratoma or Dermoid Cyst of Ovary that is often unilateral. Both of these benign tumors can occur at any age but commonly seen before 40 years of age during reproductive period of life. Other benign neoplasms like Mucinous Cystadenoma and Serous Cystadenofibroma are also seen in younger females. Brenner’s Tumor is an uncommon subtype of the surface epithelial tumors of ovary and Majority of the cases are benign in nature. This tumor is particularly seen between 40-60 years of age.

Our present study includes total 4 cases of Borderline & Malignant Neoplasms namely Serous Cystadenocarcinoma (65 years old), Granulosa Cell Tumor of Adult Type (45 years old), Dysgerminoma (32 years old) and Borderline Mucinous Tumor (48 years old).

Alternate

Fig 1a shows Struma Ovarii with extensive normal looking thyroid tissue. 1b shows Benign

Brenner’s Tumor with characteristic transitional or urothelial component giving a biphasic appearance.

 Alternate

Fig 2a shows Borderline Mucinous Tumor of ovary, a tumor with nuclear atypia and having low

malignant potential (in-between benign & malignant). 2b shows Papillary Serous Cystadenocarcinoma

of ovary with features of anaplasia and aggressiveness.

Alternate 

Fig no. 3a shows Granulosa Cell Tumor of Adult Type with characteristic Coffee-bean Nuclei.

3b shows Dysgerminoma of Ovary looking more or less similar to the classical

seminoma of the testis having clear looking cells.

 

Figure no. 1a, 1b, 2a & 2b shows microscopic photographic images of various lesions under low power magnification (H & E stain, 100x) while figure no. 3a & 3b shows images under high power magnification (H & E stain, 400x).

Discussion

Our present study includes total 100 cases of Ovarian Lesions diagnosed finally on histopathological basis. Out of them, 89% cases show unilateral lesion and 11% cases show bilateral lesions. Prakash et al found similar observation in his study with 90.9% unilateral & 9.2% bilateral lesions [4], Gurung P et al [5] with 88.15% unilateral & 11.85% bilateral lesions, Prabhakar BR& Kalyani M [6]with 90.9% unilateral & 9.1% bilateral lesionsand by Couto F et al[7]having 91.2% unilateral ovarian lesions & 8.7% bilateral lesions.So we can say that unilateral lesions are more frequent than bilateral ones and all the studies show comparable outcomes[4,5,6,7].

Broad categorization of these lesions includes Non-neoplastic cysts, BenignNeoplasms andBorderline-Malignant Neoplasms. Our present study shows 44% cases of Non-neoplastic Cysts. Similar studies like those done by Prakash A et al [4] and by Gurung P et al [5] shows 44.10% cases and 43.70% cases of Non-neoplastic Cysts respectively.In the study done by Zaman et al[8], 68.87% of the lesions are non –neoplastic in nature that is somewhat higher than other studies. Among all non-neoplastic cystic enlargements, Simple Follicular Cyst, unilateral or bilateral is the commonest one followed by Corpus Leuteal Cyst. Both of them are frequently seen among women of reproductive age and perimenopausal age. Our present study shows 20% of Follicular Cysts & 14% of Corpus Leuteal Cysts respectively. Study done by Prakash A et al [4] shows 20.1% of Follicular Cysts & 10.9% of Corpus Leuteal Cysts respectively. Gurung P et al [5]reported 17.0% of Endometriotic or Chocolate cyst, 10.4 % of Simple Follicular Cyst and 9.6 % of Corpus Leuteal Cyst and this result or outcome is not comparable with that of our present study.

Our present study shows 52% cases of benign neoplasms as well as 4% cases of borderline & malignant neoplasms. Study done by Prakash A et al [4] shows 54.14% cases of benign neoplasms as well as 1.74% cases of borderline & malignant neoplasms. Among benign neoplasms, Serous Cystadenoma is the commonest one followed by Mature Cystic Teratoma (Dermoid Cyst) or Mucinous Cystadenoma. Our present study shows 28% cases of Serous Cystadenoma, 13% cases of Mature Cystic Teratoma and 6% cases of Mucinous Cystadenoma respectively. Yogambal M et al[9] has reported 21.4% cases of Serous Cystadenoma and 19.9% cases of Mature Cystic Teratoma. Pudasaini S et al[10] has reported 40.2% cases of Serous Cystadenoma, 15.7% cases of Mature Cystic Teratoma and 9.8% cases of Mucinous Cystadenoma. Maliheh et al[11] has reported 38% cases of Serous Cystadenoma, 30% cases of Mature Cystic Teratoma and 22% cases of Mucinous Cystadenoma. Mondal et al [12] has reported 29.9% cases of Serous Cystadenoma, 15.9% cases of Mature Cystic Teratoma and 11.1% cases of mucinous cystadenoma. Iqbal et al [13] has reported 38.5% cases of Serous Cystadenoma followed by 30.8% cases of Mature Cystic Teratoma. Yasmin et al [14] has reported 24% cases of Serous Cystadenoma followed by 18% cases of Mature Cystic Teratoma. Sowe can say that outcome of all these similar studies are comparable with that of our present study.

In our study, majority of the patients (58%) belong to age group of 20-39 years followed by age group of 40-59 years (32%) and 60 years or more (10%). In our study we have not included patients who are below 20 years of age. Comparison of this age distribution with that of other similar studies is mentioned below in table no. 3.

Table No.-3:Comparison of Age Distribution of patients with ovarian lesions

Name of the Study

Age Groups in Years

0-19

20-39

40-59

60 & above

Ramachandran et al [15]

7.9%

53%

30%

9.1%

Pilli et al [16]

7%

58%

30%

5%

Kar et al [17]

7.4%

41.7%

46.2%

4.4%

Prakash A et al [4]

5.7%

53.4%

36.6%

4.3%

Present Study

----

58%

32%

10%

So we can say that results of our present study are in concordance with that of other similar studies. Ovarian lesions particularly non-neoplastic cysts & benign neoplasms are commonly seen in age group of 20-39 years of age.

Our present study includes four cases of borderline and malignant lesions. All of them are Unilateral and show different age wise incidences. Borderline Mucinous Tumor is seen at the age of 48 years. Prakash A et al [4] has also reported one case of Borderline Mucinous Tumor with age of 35 years. We have reported one case of Papillary Serous Cystadenocarcinoma in 65 years old female patient. Prakash A et al [4] has also reported one similar case with age of 56 years. Gurung P et al [5] has reported five such cases with age range of 38 to 66 years. Our present study includes one case of Dysgerminoma of Ovary with age of 32 years. Modi D et al [2] has reported one case of Dysgerminoma with age less than 20 years. Our present study also includes one case of Adult type Granulosa Cell Tumor who is 45 years old. Modi D et al [2] has reported three such cases out of which, two belongs to age group of 31-40 years and one belongs to age group of 41-50 years. Hatwal D et al [18] has reported one case of Granulosa Cell Tumor of Adult type who is 45 years old. So we can say that age wise incidence of Borderline & Malignant Neoplasms of our present study also correlate with that of other similar studies. Dysgerminoma is a malignant neoplasm of younger females while Borderline tumors and Granulosa cell tumor of Adult type are commonly seen during middle age or perimenopausal age. Serous Cystadenocarcinoma occurs at comparatively older age, usually beyond 60 years.

Conclusion

Ovarian Lesions or Enlargements, both non-neoplastic and neoplastic include a variety of morphological features and show a particular age wise incidence. Among non-neoplastic lesions, simple follicular cyst is common while among benign tumors, serous cystadenoma is common. Both are frequently bilateral. Malignant Neoplasms of Ovary are rare as compared to Benign Neoplasms and Non-neoplastic Lesions, but require a specific attention during diagnosis on both clinical and pathological basis in order to save the patient’s life.

Role of histopathological evaluation remains always important in diagnosis and management of such cases along with clinical and radiological evaluations. Histopathological study is useful to predict nature and course of ovarian lesions so that future worse outcome can be prevented with early intervention and marker study.

Contribution from authors

·   Dr. Alpesh Maru: Data collection, analysis and preparation of manuscript.

·   Dr. Chirag Menpara: Analysis and preparation of manuscript & critical revision.

Funding:Nil

Conflict of interest:None

Permission from IRB: Yes

References

1. Padubidri VG, DaftarySN.Howkins& Bourne. Pattern of ovarian lesions,Shaw’s Textbook of Gynecology, 16th edition. Elsevier; 2014:429-36.

2. Modi D, Rathod GB, Delwadia KN, Goswami HM. Histopathological pattern of neoplastic ovarian lesions. IAIM. 2016; 3(1):51-7.

3. Vinay Kumar, Abul K. Abbas, Jon C. Aster.pathology of female genital tract, Robbins and Cotran Pathological Basis of Disease,9thedition(II). Elsevier;2015(22):1023.

4. Prakash A, Chinthakindi S, Duraiswami R, Indira V.  Histopathological study of ovarian lesions in a tertiary care center in Hyderabad, India: a retrospective five-year study Int J Adv Med. 2017; 4(3):745-49.

5. Gurung P, Hirachand S, Pradhanang S. Histopathological study of ovarian cystic lesions in Tertiary Care Hospital of Kathmandu, Nepal. Journal of Institute of Medicine 2013, 35(3):44-47.

6. Prabhakar BR, Maingi K. Ovarian tumours--prevalence in Punjab. Indian J Pathol Microbiol. 1989 Oct;32(4):276-81.[pubmed]

7. Couto F, Nadkarni NS, Rebello MJ. Ovarian tumors in Goa. A Clinicopathological study. J ObstetGynecol of India. 1993; 43(3):408-12.

8. Zaman S, Majid S, Hussain M, et al. A retrospective study of ovarian tumours and tumour-like lesions. J Ayub Med Coll Abbottabad. 2010 Jan-Mar;22(1):104-8.[pubmed]

9. Yogambal M, Arunalatha P, Chandramouleeswari K, Palaniappan V. Ovarian tumors - Incidence and distribution in a tertiary referral center in South India. IOSR J Dent Med Sci. 2014; 13(2):1400-3.

10. Pudasaini S, Lakhey M, Hirachand S, et al. A study of ovarian cyst in a tertiary hospital of Kathmandu valley. Nepal Med Coll J. 2011 Mar;13(1):39-41.[pubmed]

11. Maliheh A, et al. Surgical Histopathology of Benign Ovarian Cysts: A Multicenter Study. Iranian Journal of Pathology 2010; 5(3): 132-6.

12. Mondal SK, Et al. Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10 years study in a tertiary hospital of Eastern India. J Can Res Ther2011;7:433-7.

13. Iqbal J et al. Pattern of Ovarian Pathologies. Journal of Rawalpindi Medical College (JRMC) 2013;17(1): 113-5.

14. Yasmin S, Yasmin A, Asif M. Clinicohistological pattern of ovarian tumours in Peshawar region. J Ayub Med Coll Abbottabad. 2008 Oct-Dec;20(4):11-3.[pubmed]

15. Ramachandran G, Harilal KR, Chinnamma K, Thangavelu H. Ovarian neoplasms -A study of 903 cases. J ObstetGynecol India 1972; 22:309 -15.

16. Pilli GS, Suneeta KP, Dhaded AV, et al. Ovarian tumours: a study of 282 cases. J Indian Med Assoc. 2002 Jul;100(7):420, 423-4, 447.[pubmed]

17. Kar T, Kar A, Mohapatra PC. Intra-operative cytology of ovarian tumors. J ObstetGynecol India. 2005; 55(4):345-9.

18. Hatwal D, Choudhari S, Batra N, Bhatt P, Bhatt S. Clinico-histopathological analysis of neoplastic and non-neoplastic lesion of ovary in Garhwal region of Uttarakhand: A 4 year study at tertiary level hospital. Indian Journal of Pathology and Oncology, April-June 2016; 3(2):133-140.


How to cite this article?

Maru A.M, Menapara C.B. Histopathological study of Non-neoplastic & Neoplastic ovarian lesions in a tertiary care hospital in Gujarat, India. Trop J Path Micro 2019;5(2):63-68.doi:10.17511/ jopm. 2019.i2.03.